Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies

Christa Dijkhuizen; Patrick  Korthuis; Cristina Aguado; Silvia Garcia-Román; Andrés Aguilar-Hernández; Lyndsay Drayer; Margot De Looff; Fin Milder; Anthonie van der Wekken; Anke van den Berg

Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies

Christa Dijkhuizen (First author)
, Patrick Korthuis
, Cristina Aguado
, Silvia Garcia-Román
, Andrés Aguilar-Hernández
, Lyndsay Drayer
, Margot De Looff
, Fin Milder
, Anthonie van der Wekken
, Anke van den Berg

Biomolecules & Health

Dexeus University Hospital, Pangaea Oncology
Quirón Dexeus University Hospital, Dr Rosell Oncology Institute
University of Groningen, University Medical Center Groningen, Department of Pulmonology
Rijksuniversiteit Groningen, Universitair Medisch Centrum Groningen, Afdeling Pathologie en Medische Biologie

Onderzoeksoutput: Abstract › Academic

176 Downloads (Pure)

Originele taal-2	English
Aantal pagina's	2
Status	Published - 13 jun. 2025
Evenement	European Association for Cancer Research 2025 - Lisbon, Portugal Duur: 16 jun. 2025 → 19 jun. 2025

Conference

Conference	European Association for Cancer Research 2025
Verkorte titel	EACR2025
Land/Regio	Portugal
Stad	Lisbon
Periode	16/06/25 → 19/06/25

Duurzame ontwikkelingsdoelstellingen van de VN

Deze output draagt bij aan de volgende duurzame ontwikkelingsdoelstelling(en)

SDG 03 – Goede gezondheid en welzijn

Keywords

ROS1
ROS1-remmers
cellijnen afkomstig van patiënten

Research Focus Areas Hanze University of Applied Sciences

Healthy Ageing

Research Focus Areas Research Centre or Centre of Expertise

Medical Diagnostics & Point of Care Testing
Healthcare & Biotechnology

Publinova thema's

Gezondheid

Toegang tot document

abstract EACR Lisbon C.O.DijkhuizenSubmitted manuscript, 712 KB

Citeer dit

@conference{2b3b14d88a044475b2e8ba201d20d7ba,

title = "Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies",

keywords = "ROS1, ROS1-remmers, cellijnen afkomstig van pati{\"e}nten, ROS1, ROS1 inhibitors, patient derived cell lines",

author = "Christa Dijkhuizen and Patrick Korthuis and Cristina Aguado and Silvia Garcia-Rom{\'a}n and Andr{\'e}s Aguilar-Hern{\'a}ndez and Lyndsay Drayer and \{De Looff\}, Margot and Fin Milder and \{van der Wekken\}, Anthonie and \{van den Berg\}, Anke",

year = "2025",

month = jun,

day = "13",

language = "English",

note = "European Association for Cancer Research 2025 ; Conference date: 16-06-2025 Through 19-06-2025",

}

TY - CONF

T1 - Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies

AU - Dijkhuizen, Christa

AU - Korthuis, Patrick

AU - Aguado, Cristina

AU - Garcia-Román, Silvia

AU - Aguilar-Hernández, Andrés

AU - Drayer, Lyndsay

AU - De Looff, Margot

AU - Milder, Fin

AU - van der Wekken, Anthonie

AU - van den Berg, Anke

PY - 2025/6/13

Y1 - 2025/6/13

KW - ROS1

KW - ROS1-remmers

KW - cellijnen afkomstig van patiënten

KW - ROS1

KW - ROS1 inhibitors

KW - patient derived cell lines

M3 - Abstract

T2 - European Association for Cancer Research 2025

Y2 - 16 June 2025 through 19 June 2025

ER -